Sixfold Bioscience
Delivering RNA therapies.
Winter 2018Healthcare / Healthcare -> Drug Discovery and DeliveryLondon, England, United Kingdom27 employees
Gene Therapy
Nanomedicine
Drug Delivery
About
Sixfold is focused on the commercialisation of its patented drug delivery systems for RNA therapeutics such as siRNAs for gene silencing and mRNAs for gene expression.
Build your own investing agent
GPAgent keeps YC listings public and neutral. Fund-specific scoring, notes, and workflow state live in each customer workspace.
Join the GPAgent waitlistDetails
Status
Active
Stage
Early
Team Size
27
Regions
United Kingdom, Europe